drugset / Trial / NCT04061928
Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ
NaSingle-groupOpen-labelTreatment
Summary
This study aims to investigate the safety and efficacy of radiotherapy combined with Toripalimab (PD-1 inhibitor) in the treatment of locally advanced adenocarcinoma of the gastroesophageal junction.
Timeline
- Start
- 2019-08-26
- Primary completion
- 2022-08-25
- Completion
- 2023-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Toripalimab | Monoclonal antibody | 240 mg | Other |